About David Johnson
Form D filings for Sudo Biosciences from 2023 to 2024 list David Johnson as director.
David Johnson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name David Johnson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Johnson works with at each company, as listed on that company's latest Form D.
Sudo Biosciences, Inc. · Form D/A, Feb 15, 2024
EF
Edd Fleming
Director
CG
Chris Gagliardi
Director
SB
Scott Byrd
Chief Executive Officer and director
SF
Shinichiro Fuse
Director
DE
Daniel Estes
Director